Both in Biotechnology
Silexion Therapeutics vs Calidi Biotherapeutics
Over the past year SLXN returned −99.6% and CLDI returned −97.1%; their daily moves had a correlation of 0.01.
SLXN −99.6% CLDI −97.1%Growth of $1, one year, split-adjusted
| Metric | SLXN | CLDI |
|---|---|---|
| Price | $0.1532 | $0.7018 |
| Market cap | $2.2M | $1.8M |
| Today | −7.54% | +6.33% |
| 1 month | −51.9% | −35.0% |
| 6 months | −97.6% | −79.0% |
| Year to date | −99.2% | −96.3% |
| 1 year | −99.6% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $3.1M |
| Dividend yield | — | — |
| Volatility (60d) | 240.6% | 79.5% |
| Short % of float | 3.5% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).